Simon Dumesnil - 15 Nov 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role: Director
Signature: /s/ Simon Dumesnil
Issuer symbol: KTTA
Transactions as of: 15 Nov 2022
Net transactions value: +$53,100
Form type: 4
Filing time: 17 Nov 2022, 15:34:41 UTC
Previous filing: 14 Sep 2021
Next filing: 01 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KTTA	Common Stock	Award	$10,700	+10,000		$1.07	10,000	15 Nov 2022	Direct
transaction	KTTA	Common Stock	Award	$42,400	+40,000	+400%	$1.06	50,000	17 Nov 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KTTA	Stock Option (to acquire Common Stock)	Award	$0	+100,000		$0.000000	100,000	02 Aug 2021	Common Stock	100,000	$6.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted 100,000 stock options which have a ten-year term. The option is vested and exercisable with regard to 50,000 shares of Common Stock. The remaining 50% vest, subject to Mr. Dumesnil's remaining employed and in good standing, on August 2, 2023.